MYH15 inhibitors belong to a class of chemical compounds or molecules designed to target and modulate the activity of the MYH15 gene, which encodes for the myosin heavy chain 15 protein. Myosins are a family of motor proteins responsible for various cellular functions, particularly muscle contraction and motility. MYH15, specifically, is a member of the unconventional myosin family and is primarily expressed in skeletal muscle tissues. The role of MYH15 in cellular processes, including muscle contraction and possibly other functions, is an area of ongoing research, and MYH15 inhibitors are developed to interfere with its expression or activity, enabling scientists to investigate its function within cells.
The development of MYH15 inhibitors typically involves strategies to disrupt the transcription or translation of MYH15 or to directly target the protein's function. These inhibitors may target specific regions of the MYH15 gene, such as its promoter region or transcription factors that regulate its expression. Alternatively, they may interact with the MYH15 protein itself, affecting its ATPase activity or its ability to interact with other cellular components. By modulating MYH15, these inhibitors can shed light on the protein's roles in muscle physiology or other cellular processes, offering valuable insights into the molecular mechanisms governing muscle contraction and potential broader functions within cells. The study of MYH15 inhibitors contributes to our understanding of the intricate biology of myosins and their contributions to cellular motility and other processes.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Dantrolene | 7261-97-4 | sc-500165 | 25 mg | $350.00 | 7 | |
As a muscle relaxant, dantrolene might influence calcium ion channels in muscle cells, potentially affecting MYH15 expression in muscle tissues. | ||||||
(RS)-Atenolol | 29122-68-7 | sc-204895 sc-204895A | 1 g 10 g | $77.00 $408.00 | 1 | |
A beta-blocker used to manage cardiovascular conditions; it might indirectly influence myosin expression in cardiac muscle. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $367.00 | ||
A calcium channel blocker that affects muscle contraction, potentially influencing the expression of myosins like MYH15. | ||||||
Colchicine | 64-86-8 | sc-203005 sc-203005A sc-203005B sc-203005C sc-203005D sc-203005E | 1 g 5 g 50 g 100 g 500 g 1 kg | $98.00 $315.00 $2244.00 $4396.00 $17850.00 $34068.00 | 3 | |
Known for its ability to disrupt microtubule formation, colchicine might indirectly affect muscle cell function and myosin expression. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 5 g 100 g 250 g 1 kg 5 kg | $32.00 $66.00 $95.00 $188.00 $760.00 | 13 | |
As a stimulant, caffeine affects calcium release in muscle, which might indirectly influence MYH15 expression. | ||||||
Bisoprolol | 66722-44-9 | sc-278792 | 25 mg | $204.00 | ||
Another beta-blocker that might affect cardiac muscle physiology and potentially influence MYH15 expression. | ||||||
Losartan | 114798-26-4 | sc-353662 | 100 mg | $127.00 | 18 | |
An angiotensin receptor blocker, losartan might affect cardiovascular physiology, potentially influencing myosin expression. | ||||||
12β-Hydroxydigitoxin | 20830-75-5 | sc-213604 sc-213604A | 1 g 5 g | $140.00 $680.00 | ||
As a cardiac glycoside, 12β-Hydroxydigitoxin affects heart muscle contractility, which could indirectly influence MYH15 expression in cardiac muscle. | ||||||
Propranolol | 525-66-6 | sc-507425 | 100 mg | $180.00 | ||
A non-selective beta-blocker, propranolol might affect heart muscle physiology and indirectly influence myosin expression. | ||||||
Simvastatin | 79902-63-9 | sc-200829 sc-200829A sc-200829B sc-200829C | 50 mg 250 mg 1 g 5 g | $30.00 $87.00 $132.00 $434.00 | 13 | |
As a statin, simvastatin affects cholesterol metabolism, but might also have effects on muscle cells, potentially influencing MYH15 expression. |